Increased Circulating Levels of Vascular Endothelial Growth Factor in Preeclampsia

References

• Fox H. Pathology of the placenta. W.B. Saunders, London 1978; 255–73
   Google Scholar
• Spargo B, McCartney C P, Winemiler R. Glomerular capillary endotheliosis in toxemia of pregnancy. Arch Pathol 1959; 68: 593–9
   PubMedGoogle Scholar
• Brown M A, Zammit V C, Lowe S A. Capillary permeability and extracellular fluid volumes in pregnancy‐induced hypertension. Clin Sci 1989; 77: 599–604
   PubMed Web of Science ®Google Scholar
• Nova A, Sibai B M, Barton J R, Mercer B M, Mitchell M D. Maternal plasma level of endothelin is increased in pre‐eclampsia. Am J Obstet Gynecol 1991; 165: 724–7
   PubMed Web of Science ®Google Scholar
• Taylor R N, Crombleholme W R, Friedman S A, Jones L A, Casal D C, Roberts J M. High plasma cellular fibronectin levels correlate with biochemical and clinical features of pre‐eclampsia but cannot be attributed to hypertension alone. Am J Obstet Gynecol 1991; 165: 895–901
   PubMed Web of Science ®Google Scholar
• Ashworth J R, Baker P N, Warren A Y, Johnson I R. Loss of endothelium‐dependent relaxation in myometrial resistance arteries in pre‐eclampsia. Br J Obstet Gynaecol 1997; 104: 1152–8
   PubMedGoogle Scholar
• Branch D W, Dudley D J, LaMarche S, Mitchell M D. Sera from pre‐eclamptic patients contains factor(s) that stimulate prostacyclin production by human endothelial cells. Prost Leukot Essential Fatty Acids 1992; 45: 191–5
   PubMed Web of Science ®Google Scholar
• Roberts J M, Edep M E, Goldfein A, Taylor R N. Sera from pre‐eclamptic women specifically activate human umbilical vein endothelial cells in vitro. Am J Reprod Immunol 1992; 27: 101–8
   PubMed Web of Science ®Google Scholar
• Roberts J M, Taylor R N, Musci T J, Rodgers G M, Hubel C A, McLaughlin M K. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989; 161: 1200–4
   PubMed Web of Science ®Google Scholar
• Jackson M R, Carney E W, Lye S J, Ritchie J W K. Localisation of two angiogenic growth factors (PDECGF and VEGF) in human placentae throughout gestation. Placenta 1994; 15: 341–53
   PubMed Web of Science ®Google Scholar
• Senger D, Galli S J, Dvorak A M, Perruzzi C A, Harvey V S, Dvorak H F. Tumour cells secrete a vascular permeability factor which promotes ascites fluid accumulation. Science 1983; 219: 983–5
   PubMed Web of Science ®Google Scholar
• Clauss M, Gerlach M, Gerlach H, et al. Vascular permeability factor: a tumor derived polypeptide that induces endothelial cell and monocyte procoagulant activity and promotes monocyte migration. J Exp Med 1990; 172: 1535–45
   PubMed Web of Science ®Google Scholar
• Halligan A, Bonnar J, Sheppard B, Darling M, Wilshe J. Haemostatic, fibrinolytic and endothelial variables in normal pregnancies. Br J Obstet Gynecol 1994; 101: 488–92
   PubMedGoogle Scholar
• Musci T J, Roberts J M, Rodgers G M, Taylor R N. Mitogenic activity is increased in the sera of pre‐eclamptic women before delivery. Am J Obstet Gynecol 1988; 159: 1446–51
   PubMed Web of Science ®Google Scholar
• Houck K A, Ferrara N, Winer J, Cachianes G, Li B, Leung D W. The vascular endothelial growth factor family: identification of a fourth molecular species and characterisation of alternative splicing of RNA. Mol Endocinol 1991; 5: 1806–14
   PubMed Web of Science ®Google Scholar
• Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia initiated angiogenesis. Nature 1992; 359: 843–5
   PubMed Web of Science ®Google Scholar
• Baker P N, Krasnow J, Roberts J M, Yeo K ‐T. Elevated serum levels of vascular endothelial growth factor in patients with pre‐eclampsia. Obstet Gynecol 1995; 86: 815–21
   PubMed Web of Science ®Google Scholar
• Sharkey A M, Cooper J C, Balforth J R, McClaren J, Clark D E, Charnock‐Jones D S, et al. Maternal plasma levels of vascular endothelial growth factor in normotensive pregnancies and in pregnancies complicated by pre‐eclampsia. Eur J Clin Invest 1996; 26: 1182–5
   PubMed Web of Science ®Google Scholar
• Lyall F, Greer I A, Boswell F, Fleming R. Suppression of serum vascular endothelial growth factor immunoreactivity in normal pregnancy and in pre‐eclampsia. Br J Obstet Gynecol 1996; 104: 223–9
   Google Scholar
• Anthony F W, Evans P W, Wheeler T, Wood P J. Variation in detection of VEGF in maternal serum by immunoassay and the possible influence of binding proteins. Ann Clin Biochem 1997; 34: 1–5
   PubMed Web of Science ®Google Scholar
• Davey D A, MacGillivary I. The classification and definition of pre‐eclampsia. Am J Obstet Gynecol 1988; 15: 892–8
   Google Scholar
• Ferrara N, Houck K, Jakeman L, Leung D W. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocrin Rev 1992; 13: 18–32
   PubMed Web of Science ®Google Scholar
• Davidge S, Signorella A P, Hubel C A, Lykins D L, Roberts J M. Distinct factors in plasma of preeclamptic women increase endothelial nitric oxide or prostacyclin. Hypertension 1996; 28(5)758–64
   PubMed Web of Science ®Google Scholar
• Baker P N, Davidge S, Roberts J M. Plasma from women with pre‐eclampsia increases endothelial cell nitric oxide production. Hypertension 1995; 26: 244–8
   PubMed Web of Science ®Google Scholar
• Wu H M, Haung Q B, Yaun Y, Granger H J. VEGF induces NO‐dependent hyperpermeability in coronary vessels. Am J Physiol 1996; 40: H2735–9
   Google Scholar
• Sharkey A M, Charnock‐Jones D S, Boocock C A, Brown K D, Smith S K. Expression of mRNA for vascular endothelial growth factor in human placenta. J Reprod Fertil 1993; 99: 609–15
   PubMedGoogle Scholar
• Clarke D E, Smith S K, Sharkey A M, Charnock‐Jones D S. Localisation of VEGF and expression of its receptors flt‐1 and KDR in the human placenta throughout pregnancy. Hum Reprod 1996; 11: 1090–8
   PubMed Web of Science ®Google Scholar
• Wheeler T, Elcock C L, Anthony F W. Angiogenesis and the placental environment. Placenta 1995; 16: 289–96
   PubMed Web of Science ®Google Scholar
• Cooper J C, Sharkey A M, Charnock‐Jones D S, Palmer C R, Smith S K. VEGF mRNA levels in placentae from pregnancies complicated by pre‐eclampsia. Br J Obstet Gynaecol 1996; 103: 1191–6
   PubMedGoogle Scholar
• Alverez H, Benedetti W L, Morel R L, Scavarelli M. Trophoblast development gradient and its relationship to placental hemodynamics. Am J Obstet Gynecol 1970; 106: 416–20
   PubMed Web of Science ®Google Scholar
• Kendall R L, Thomas K A. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc Natl Acad Sci USA 1993; 90: 10705–9
   PubMed Web of Science ®Google Scholar